Op-Ed
Mark Schultz And Jennifer Brant
Not MetaphorsLawmakers recently held a hearing on how to balance pharmaceutical innovation and patient access. Predictably, the discussion returned to two familiar themes: so-called patent 'thickets' and 'evergreening.
Wednesday, June 24, 2026